Decreased Immunologic Activity [PE]: Side Effects & Safety Data for 2 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Decreased Immunologic Activity [PE] includes 2 drugs with a combined 51,011 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
2
Drugs in Class
51,011
Combined Reports
All Decreased Immunologic Activity [PE] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| EVEROLIMUS | EVEROLIMUS | 39,640 | 8,374 | 11,211 | 21.1% |
| SIROLIMUS | sirolimus | 11,371 | 1,737 | 3,535 | 15.3% |
Common Side Effects in Decreased Immunologic Activity [PE] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Death | 5,476 | 5,448 |
| Malignant neoplasm progression | 3,842 | 1,145 |
| Diarrhoea | 3,432 | 397 |
| Off label use | 3,245 | 425 |
| Fatigue | 3,158 | 364 |
| Stomatitis | 2,873 | 216 |
| Drug ineffective | 2,842 | 399 |
| Nausea | 2,308 | 251 |
| Dyspnoea | 2,130 | 466 |
| Product use in unapproved indication | 2,042 | 324 |